| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 011913 | AS 602801 | 848344-36-5 | 98% | ![]() |
| AS 602801 is a novel, orally active inhibitor of JNK. | ||||
| 011911 | AMG232 | 1352066-68-2 | 98% | ![]() |
| AMG232 is an extremely potent MDM2 inhibitor (SPR KD = 0.045 nM, SJSA-1 EdU IC50 = 9. | ||||
| 011905 | Afdx 384 | 118290-27-0 | 98% | ![]() |
| Coming soon! | ||||
| 011813 | Avoralstat | 918407-35-9 | 95.0% | ![]() |
| Avoralstat(前身为BCX4161)是一种有效的小分子口服血浆激肽释放酶 | ||||
| 01181 | AMG-337 | 1173699-31-4 | 98% | ![]() |
| AMG-337 is a potent and highly selective small molecule ATP-competitive MET kinase in | ||||
| 011803 | AMG 900 | 945595-80-2 | 98% | ![]() |
| AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/ | ||||
| 011802 | APTO-253 | 1422731-37-0 | 98% | ![]() |
| APTO-253 is a small molecule inhibitor of human metal-regulatory transcription factor | ||||
| 011302 | AC-55541 | 916170-19-9 | 98% | ![]() |
| AC-55541 is a novel small-molecule protease-activated receptor 2(PAR2) agonist. | ||||
| 011120 | AZ 628 | 878739-06-1 | 98% | ![]() |
| AZ628 is a new pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 105 nM | ||||
| 011117 | AZD-5582 | 1258392-53-8 | 98% | ![]() |
| AZD5582 is a potent IAP inhibitor, which is a dimeric compound based on the AVPI moti | ||||
| 011111 | Arbidol hydrochloride | 131707-23-8 | 98% | ![]() |
| Arbidol is an broad-spectrum antiviral chemical agent which can inhibit cell entry of | ||||
| 011108 | APY29 | 1216665-49-4 | 98% | ![]() |
| APY29 is an allosteric modulator of IRE1; inhibits IRE1 autophosphorylation (IC50 = 2 | ||||
| 011107 | AMG-47a | 882663-88-9 | 98% | ![]() |
| AMG-47a is a potent inhibitor of Lck and T cell proliferation. | ||||
| 011104 | ARQ-736 | 1228237-57-7 | 98% | ![]() |
| ARQ 736 is a potent and selective BRAF inhibitor. | ||||
| 010820 | AZD4547 | 1035270-39-3 | 98% | ![]() |
| AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2 | ||||
| 010816 | AZD-1480 | 935666-88-9 | 98% | ![]() |
| AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM, selectivity a | ||||
| 25152 | Avutometinib ( 别名: Ro 5126766; CH5126766 ) | 946128-88-7 | ≧98.0% | ![]() |
| Avutometinib(别名:RO-5126766、CH-5126766)是一种正在开发的 Ras-Raf-ME | ||||
| 010809 | AZD8330 | 869357-68-6 | 98% | ![]() |
| AZD8330 is a novel, selective, non-ATP competitive MEK 1/2 inhibitor with IC50 of 7 n | ||||
| 010808 | AS703026 | 1236699-92-5 | 98% | ![]() |
| AS703026 is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) | ||||
| 010803 | AZ505 | 1035227-43-0 | 98% | ![]() |
| AZ505 is a potent and highly selective inhibitor of the oncogenic protein SMYD2(IC50= | ||||
| 010428 | AG-L-59687 | 793035-88-8 | 98% | ![]() |
| Coming soon! | ||||
| 010422 | AG1024 | 65678-07-1 | 98% | ![]() |
| AG-1024 inhibits IGF-1R autophosphorylation with IC50 of 7 M, less potent to IR with | ||||
| 010418 | Almotriptan | 154323-57-6 | 98% | ![]() |
| Almotriptan is a 5-HT1B/1D-receptor agonist used to treat migraine. | ||||
| 010410 | AM630 | 164178-33-0 | 98% | ![]() |
| AM630 is a selectivity CB2 antagonist with Ki of 31.2 nM; > 150 fold selectivity o | ||||
| 123019 | AZD-8055 | 1009298-09-2 | 98% | ![]() |
| AZD-8055 is an inhibitor of the mammalian target of rapamycin (mTOR) with potential a | ||||
| 123016 | Amuvatinib | 850879-09-3 | 98% | ![]() |
| Amuvatinib is a potent and multi-targeted inhibitor of c-Kit, PDGFR and Flt3 with IC5 | ||||
| 123009 | AR-42 | 935881-37-1 | 98% | ![]() |
| AR-42 is a novel, oral cancer therapy currently in early clinical development. | ||||
| 123006 | A-966492 | 934162-61-5 | 98% | ![]() |
| A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 n | ||||
| 122942 | AMG 487 | 473719-41-4 | 98% | ![]() |
| AMG 487 is a small molecule antagonist of the chemokine receptor CXCR3. | ||||
| 122931 | Atosiban acetate | 90779-69-4 | 98% | ![]() |
| Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/ | ||||
